(: NVO)

Overview
current price
$0.00
$0.00
change
0.00 | 0.00%
0.00 | 0.00%
Yesterday's Close
0.00
open
0.00
volume
0.00 M
30d. avg volume.
0.00 M
1 day
0.00 - 0.00
52 weeks
0.00 - 0.00
p/e
0.00
beta
0.0000
market cap
0.00 B
dividend yield
0.00%
Industry
-
News and Commentary
Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs Novo Nordisk (NVO
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs Novo Nordisk A/S (NVO
Hims & Hers Super Bowl Ad For Cancer Test Raises Questions Over Reliability The Super Bowl ad by Hims & Hers (
Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans Super Bowl LX aired on Sunday, Feb. 8, 2026, and the Seattle Seahawks defeated the New England Patriots 29-13, in a game that saw 30 of the 42 total points scored in the fourth q...
In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk Over the last two days, Novo Nordisk A/S (
Novo Nordisk's Next-Gen Combination Drug Beats Semaglutide in Weight Loss and Blood Sugar Control Novo Nordisk A/S (NVO
Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says Novo Nordisk A/S (NVO&n...
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk Novo Nordisk's (NVO&nbs...
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx President Donald Trump on Thursday announced agreements with Eli Lilly and Co.
Market Update: Dow Falls 400 Points as AI Stock Valuations Pressure Outlooks Stocks fell lower on Thursday as market participants grew more cautious over the high artificial intelligence stock valuations, which appear to be propping up the broader market....
StockTwits
StockTwits

Join now and unlock premium features